Strykr Analysis
BullishStrykr Pulse 62/100. Defensive rotation is building, technicals favor a breakout. Threat Level 2/5.
You can almost hear the collective yawn from Wall Street when healthcare comes up in the morning meeting. While the AI crowd is busy chasing Nvidia’s shadow and tech headlines dominate the tape, the Health Care Select Sector SPDR Fund (XLV) has been quietly holding the line at $146.34. Flat as a pancake, sure, but beneath the surface, the sector is quietly gathering steam. Ignore the lack of fireworks at your own risk, this is the kind of slow-burn rotation that catches the fast money offside.
Let’s start with the facts. XLV hasn’t moved much, $146.34, unchanged on the day, and barely budged all week. But look closer and you’ll see the sector’s resilience is starting to look like relative strength. While tech and chip stocks have been running hot, healthcare has been the wallflower at the bull market party. That’s exactly why it’s interesting. The last time tech leadership wobbled, healthcare was the first place the money went. With AI trades looking crowded and the “Mag 7” showing signs of exhaustion, the setup for a rotation into healthcare is quietly building.
Recent news has been all about AI infrastructure bottlenecks, data center delays, and the Fed’s new chair making waves. But in the background, healthcare is quietly outperforming on a risk-adjusted basis. The sector’s earnings have been solid, balance sheets are fortress-like, and the regulatory backdrop is as benign as it gets. No major policy shocks, no reimbursement drama, just steady-as-she-goes fundamentals. That’s not sexy, but it’s exactly what you want when the rest of the market is jittery.
The macro context is shifting. With US equities at record highs and volatility scraping the bottom, the risk of a correction is rising. The AI trade is starting to look like a game of musical chairs, and when the music stops, the money will look for safety. Healthcare is the obvious beneficiary. The sector has underperformed tech by nearly 12% YTD, but the gap is starting to close. Flows into defensive sectors are picking up, and XLV is quietly attracting institutional money. The last time this happened, XLV outperformed the S&P 500 by +8% over the following quarter.
From a technical perspective, XLV is coiling just below resistance at $148. The 50-day moving average is rising, RSI is neutral, and the sector is sitting on a base that has held for months. Volume is picking up, and options open interest is skewed to the upside. The setup is classic: a sector that’s been ignored, building a base, and ready to break out as soon as the narrative shifts.
Strykr Watch
Here’s what matters: $145 is strong support, with buyers stepping in every time the sector dips. Resistance is at $148, a clean break above that level opens the door to $153, a level that would put healthcare back on the radar for momentum funds. The 200-day moving average is rising, and implied volatility is cheap relative to realized. If you’re looking for a sector that’s quietly setting up for a rotation, this is it.
The risk is that the market stays irrational longer than you can stay solvent. If tech keeps ripping, healthcare could stay in the penalty box. But the odds are shifting. The technicals are improving, flows are picking up, and the sector’s defensive qualities are starting to look attractive as the rest of the market gets frothy.
The bear case is that healthcare remains a value trap, stuck in a range while tech continues to dominate. But the setup is asymmetric. If the market corrects, healthcare will outperform. If the rotation kicks in, XLV could lead the next leg higher.
On the opportunity side, this is a textbook case for buying the breakout. Go long above $148 with a stop at $145 and a target at $153. Options are cheap, and the risk-reward is compelling. If you’re looking for a way to hedge tech exposure, this is the play.
Strykr Take
Healthcare is the sector everyone loves to ignore, until it isn’t. With the market stretched and the AI trade looking crowded, XLV is quietly setting up for a run. The technicals are improving, the flows are turning, and the risk-reward is skewed to the upside. Don’t sleep on this rotation. Strykr Pulse 62/100. Threat Level 2/5.
Buy the breakout above $148, keep a tight stop, and let the tape do the work. When the market finally wakes up to healthcare, you’ll want to be there first.
Sources (5)
America's Data Center Build-Out Is Falling Way Behind Schedule
Google, which is raising a fresh $80 billion, has a strategy for getting around the biggest bottleneck.
Fed Chair Warsh makes first hires at central bank, including ‘Project 2025' author
Kevin Warsh has made his first two hires after his swearing-in as Federal Reserve chair last month, according to a person familiar with the matter. Th
Goldberg: Expect "Hiccups" in Strong AI Trend, Look "Below" Mag 7 Stocks
While the AI trade is showing little signs of weakness, it's good to stay diversified as a pullback is inevitable, argues Andy Goldberg. He believes t
China is making it harder for Mom and Pop to access U.S. stocks. Here's who will benefit
China is tightening the screws on a long-running way its retail investors could access Wall Street securities. Analysts say it further reinforces a lo
Review & Preview: Triple Whammy
Tech and chip stocks pushed the major indexes to fresh highs as Nvidia gave a major boost to Marvell Technology. Plus, a look into Google's $80 billio